Co-Founder, Lead Scientist, And Coo
Current• Establishing and equipping a cutting-edge research laboratory, driving initial scientific exploration to support fundraising efforts.• Pioneering the development of iPSC-derived brain organoid models, enabling high-throughput screening for potential therapeutics targeting Parkinson's disease, Rett syndrome, and CDKL5 deficiency disorder.• Contributed to design and implementation of an AI-driven drug discovery platform leveraging scRNA-seq foundation models fine-tuned on organoid data; recognized with the prestigious NVIDIA Prize at the 2024 Bio x ML Hackathon.• Overseeing daily operations, including strategic planning, information management, and execution of the company's vision.